OTTAWA, ON, Nov. 20, 2025 /CNW/ - Intouch Insight Ltd, ("Intouch" or "the Company") (TSXV: INX) (OTCQX: INXSF) a leader in customer experience measurement solutions, today announced financial results ...

The new Kronos IEMs from have nine drivers and a six-way crossover but an impedance of less than 35Ω. Noble Audio has announced the launch of its latest pair of flagship in-ear monitors. The Kronos ...

Noble Kronos flagship IEMs deliver cutting-edge 9-driver hybrid sound with titanium shells. Are these $4,500 earphones worth the hype and price? Now, before you roll your eyes at the $4,500 price tag ...

Kronos is a HOLD: TiO2 demand should rise, but KRO lacks operating leverage and control over key feedstocks to benefit from upside. KRO faces significant competition from Chinese producers, especially ...

With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences. Tang Capital Partners’ Concentra inked a definitive deal to acquire Kronos’ ...

(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...

Performances in N.Y.C. Advertisement Supported by The venerable quartet returned to Zankel Hall with a typically eclectic program and a newfound emotional intensity. By Corinna da Fonseca-Wollheim The ...

Over 99% of Intouch stockholders approve merger with Gulf Energy Merger to form $25 billion entity, LSEG shows Gulf and Intouch announced last July that they planned to merge to combine their energy ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. INDIANAPOLIS — There have been seven ...

NAMM 2025: Korg has revived its beloved Kronos workstation, unveiling an updated model that promises to be faster and more flexible then previous incarnations, as well as being packed with fresh ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...

Kronos Q324 sales volumes soared, offsetting flat TiO2 selling prices to deliver +22% YoY revenue growth along with improved profitability. The company faces high growth expectations as it integrates ...